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1 Background
Use of antibiotics for animals in the Netherlands has
reduced considerably over the last 5 years. This
reduction is the result of a change in policy towards
the use of antibiotics in veterinary practice and is
characterized by a series of coherent political deci-
sions which changed the playing field for farmers
and veterinarians considerably. In the years before
the reducing trend in use of antibiotics started off,
the Netherlands was a relative high consumer of
antibiotics in veterinary practice. The trends in anti-
biotic use will be explored in this paper, in particular
focussing on the reducing trends in recent years, and
the measures which led to the strong reducing trend
which can be observed over a period of more than
3 years now.
2 The years of high use of antibiotics in livestock
production
Antibiotic use in animals in the Netherlands is
measured as sales data since 1999 by the Association
of Veterinary Pharmacy in the Netherlands (FIDIN)
(Anonymous 2013). The sales data are considered to
provide a good estimate of the use of antibiotics in
animals licenced for therapy on prescription by vet-
erinarians. However, specification by animal species
is not possible, since many products are licensed to
be used in multiple animal species. Sales of antibi-
otics increased from approximately 300 tons in 1999
till almost 600 tons in 2007 (Fig. 1). In that period the
use of antimicrobial growth promoters in the Nether-
lands was phased out and reduced from a use of 250
tons in 1999 to zero tons in 2006, the result of the ban
of these substances by the European Commission.
Because the number of Dutch livestock animals
produced remained stable, it can be concluded that
the antimicrobial growth promoters were fully
replaced by increased therapeutic use by veterinari-
ans (Anonymous 2013). Animal treatments outside
the livestock industry only contributed marginally to
the overall sales data.
Apparently, systematic use of cheap antibiotics was
considered more cost effective for intensive animal
production, than implementing stringent health and
infection control programs. Moreover, the control on
prudent antibiotic use was insufficient until 2008.
Based on these sales data, the European Surveil-
lance of Antibiotic Use working group (ESVAC) of the
European Medicine Agency in London reported in
2012 that in the Netherlands most antibiotics were
used per kg live weight produced (Grave et al. 2012).
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3 Prudent use of antibiotics in human medicine
in the Netherlands
In contrast, in Dutch human medicine, use of anti-
biotics can be considered as essentially prudented. In
patients in the Netherlands, antibiotic use is among
the lowest of Europe (Elseviers et al. 2007; Vander
Stichele et al. 2006). As a result microbial resistance
levels in health care are low, as illustrated by the low
level of Methicillin Resistant Staphylococcus aureus
(MRSA) infections. These occur only incidentally in
invasive infections in hospitals (EARSNET-20131). Also
the occurrence of cefotaxime resistant isolates sus-
pected to produce Extended Spectrum Beta-
Lactamases (ESBLs) in infections in hospitals, is lower
than in most other European countries (EARSNET-
2013). This enormous contrast in antibiotic use in
veterinary and human medicine practice feeds the
negative perception of medical doctors, authorities
and the public about live-stock production in the
Netherlands. Moreover, the consequence is also that
any potential contribution of resistant organisms
from animals to human infections in health care is
more visible in routine statistics and has a higher
potential contribution to disease load than in coun-
tries with high usage in human health care and with
endemic occurrence of multi-drug resistant organ-
isms in hospitals.
A result of the high use of antibiotics in animals, is
that resistance levels are high in food-producing
animals as reported in the annual reports of the
Dutch Monitoring of Antibiotics use and Resistance
in Animals program (Anonymous 2013). Resistance
levels are most optimally measured in the intestinal
flora of healthy animals (Anonymous 2008). Com-
mensal E. coli isolated according to EFSA protocols is
used as indicator organism of the Gram-negative
intestinal flora.Multi-drug resistance levels in E. coli are
high and increased up to 2009 in isolates from broilers,
pigs, and veal calves and toa lesser extend in those from
dairy cattle (Anonymous 2008). This indicates that the
gastro-intestinal tract of food-animals is a (potential)
reservoir of multi-drug resistant organisms.
4 Events leading to increased attention for high
veterinary use of antimicrobials
Livestock MRSA (ST398) was first detected in a Dutch
pig farm in 2005 (Voss et al. 2005). Surveillance tar-
geted at MRSA prevalence showed that most pig and
veal calf farms are positive for MRSA, and that this
organism can also be found in companion animals,
horses, poultry and meat products.2 The transmission
route of MRSA to humans is direct contact, and
farmers and veterinarians are considered to be at risk
to be MRSA carriers (Dorado-Garcia et al. 2013; Gilbert
et al. 2012; Graveland et al. 2011). Patients at risk to
carry MRSA are nursed and treated in isolation in
hospitals to prevent spread of MRSA (Voss 2004;
Wassenberg et al. 2010). The frequent occurrence of
MRSA ST398 has resulted in human infections,
although MRSA ST398 is generally not considered a
highly pathogenic micro-organism, but in particular
had a major effect on increased costs in health
care, which has increased the level of concern of
health care authorities regarding Dutch livestock
Fig. 1 Sales of antimicrobials for therapeutic use on prescription
in animals (purple bars) and sales of antimicrobial growth
promoters from 1999 to 2009 in the Netherlands (Source: FIDIN)
(color figure online)
1 European Centre for Disease Prevention and Control. Anti-
microbial resistance surveillance in Europe 2012. Annual
Report of the European Antimicrobial Resistance Surveillance
Network (EARS-Net). Stockholm: ECDC; 2013. http://www.ecdc.
europa.eu/en/healthtopics/antimicrobial_resistance/database/
Pages/map_reports.aspx.
2 Analysis of the baseline survey on the prevalence of me-
thicillin-resistant Staphylococcus aureus (MRSA) in holdings
with breeding pigs, in the EU, 2008, Part A: MRSA prevalence
estimates; on request from the European Commission. EFSA
Journal 2009; 7(11):1376 [82 pp.]. doi:10.2903/j.efsa.2009.1376.
Available online: www.efsa.europa.eu.
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production. The emergence of MRSA was paralleled
by occurrence of ESBL-producing organisms in live-
stock production. Since 2002 the occurrence of ESBL-
producing organisms has been observed in broilers
(Dierikx et al. 2010). Both in E. coli and in Salmonella a
rapid increase was observed of ESBL-producers in
these animals. A prevalence study showed that all
broiler farms were positive and virtually all animals
shed ESBL-producing E. coli in their faeces (Dierikx
et al. 2013). As a result almost all broiler meat pro-
ducts were positive for ESBL-producing organisms
(Cohen Stuart et al. 2012; Overdevest et al. 2011). A
large study conducted with the University Medical
Centre of Utrecht (UMCU) and the Dutch Institute for
Public Health and the Environment (RIVM) showed
that one in five human clinical ESBL-producing isolates
harboured genes and plasmids that seemed indistin-
guishable frompoultry genes and plasmids (Leverstein-
van Hall et al. 2011). Poultry meat was considered a
potentially likely route of transmission tohumans. Data
frompoultry sources and from subsequent screening in
other food-animals, dogs andwild birds demonstrating
high prevalences further raised concerns about
the possible attribution of ESBLs from animal related
sources to infections in humans.
5 Reducing the use of antimicrobials in veterinary
practice
The concerns about public health consequences of
antibiotic usage and resistant organisms in animals
to human health have resulted in drastic changes in
the policy of the Dutch authorities. In 2008 already
the Dutch minister of Agriculture, Nature and Food
Quality, installed a task force on Antimicrobial
Resistance in Food Animals and demanded the
combined stakeholders involved in animal produc-
tion and the Dutch Royal Veterinary Association
(KNMvD) to sign memoranda of understanding in
which measures to reduce antibiotic use and anti-
microbial resistance are described. After a debate in
parliament about ESBLs in poultry, mandatory
reduction targets in antibiotic usage in animals in
the Netherlands were defined as 20 % reduction in
2011 and 50 % in 2013. In 2012 this target was renewed
to 70 % reduction for total livestock production. As
reference year 2009 was defined. Different initiatives
were taken resulting in a measurable reduction in
the use of antibiotics:
• An essential element in the approach of the task
force was to make antibiotic use on all farms
transparent. Since 2012 it is mandatory to register
all antibiotics supplied by veterinarians. This was
already partially implemented by the private
stakeholders in animal production in 2011 in veal
calves, broilers and pigs as part of their quality
systems. In particular by means of the quality
systems acting at the sector level, they were able
to implement these policies swiftly and effectively.
In 2012 cattle followed. Usage on farms is
expressed as animal daily dosages per year (add/y)
(Bos et al. 2013), which resembles the Danish
system of reporting.3 In this way farms and vets
can be benchmarked and compared with each
other and with independently defined targets
(benchmarking). An essential part of this process
was to install an independent institute to control
the use data, report the data publically and to
define targets for use. In spring 2011 the Nether-
lands Veterinary Medicines Authority (SDa: www.
autoriteitdiergeneesmiddelen.nl) was installed for
this purpose and the first targets for use in dif-
ferent animal production sectors were published
in July 2011.
• Because of the concerns about MRSA and ESBLs in
food-animals, the Dutch Heath Council was asked
to advice the Ministers of Public health Welfare
and Sports and the Minister of Economic Affairs
about antibiotic usage in animals. The advice
included a full ban in usage of any new antibac-
terial drug in animals and a restriction of the use
of 3rd and 4th generation cephalosporins in
animals. Moreover, it was advised to restrict the
use of colistin, all beta-lactams, aminoglycosides
and fluoroquinolones in food-animals. Since this
advice lacked detail, the Antibiotics Policy Work-
ing Group (WVAB) of the KNMvD, wrote a
guideline in which drugs were classified as first,
second and third choice drugs for inclusion in
treatment plans on farms (http://wvab.knmvd.nl/
wvab). Moreover, the animal drug law was chan-
ged in 2013, ruling that only first choice drugs are
allowed to be present on farms for empiric treat-
ment of infections based on a mandatory
treatment plan for each farm. This treatment plan
has to be custom made by the veterinarian for
each farm, based on treatment guidelines of the
KNMvD (formularia: http://wvab.knmvd.nl/wvab/
formularia/formularia).
3 DANMAP 2012. Use of antimicrobial agents and occurrence
of antimicrobial resistance in bacteria from food animals, food
and humans in Denmark. ISSN 1600–2032.
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• In 2013 the SDa has defined quantitative reduction
targets for antibiotic use for each food-animal
species (in add/y) including zero add/y as quanti-
tative target for fluoroquinolones and 3rd, and
4th generation cephalosporins. The latter two
drugs are only allowed after it has been proven
that no alternative treatment options are avail-
able. This is also regulated in 2013 by the change
in the animal drug law. In the meantime, most
animal production sectors have voluntarily
decided to stop usage of these third choice drugs
in animals on a voluntary basis.
As a result of all these measures taken, sales of
antibiotics have decreased in 5 years by 56 % since
2007 and the target of 50 % reduction in 2013 is
already reached in 2012 (Fig. 2). Moreover, clear
indications exist that the occurrence of antimicrobial
resistance in animal bacteria and the load of ESBLs in
animals is decreasing (Anonymous 2013). This is a
very important result of the governmental targets,
the measures initiated by the private parties involved
in animal production and the SDa, which can be
considered to be critical success factors for the
Netherlands.
However, to solve the current and future threats of
multi-drug resistant organisms in (food)-animals to
human health, a substantial further reduction may
be warranted and on the longer term a change in
animal production practices cannot be excluded. In
2014 next to livestock farms, veterinarians will also be
benchmarked. A system has been developed which
describes the use of antimicrobials on the population
of farms for which a veterinarian is responsible. To
facilitate this approach, regulations were put in place
which resulted in unique one on one relations
between veterinarians and livestock farmers. Further
refinements in the benchmarking system are to be
expected.
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